Asparaginase Erwinia chrysanthemi Shortage
Last Updated: June 11, 2024
Status: Current
Reason for the Shortage
-
- Erwinaze supply disruption is due to the license being withdrawn from Jazz and Porton Biopharma Limited (PBL) is in the process of obtaining the license in the United States. It is unclear when product will be back again.
- Jazz Pharmaceuticals has Rylaze (asparaginase erwinia chrysanthemi (recombinant)-rywn) available through specialty distributors. Additional information can be found at https://www.rylaze.com/ordering-information.
Available Products
-
- Rylaze solution for injection, Jazz Pharmaceuticals, 10 mg, 0.5 mL single dose vial, 3 count, NDC 68727-0900-03
Implications for Patient Care
-
- As of mid-December 2021, Clinigen is no longer providing Erwinase for personal importation to patients in the US
Updated
Updated June 11, 2024 by Michelle Wheeler, PharmD, Drug Information Specialist. Created October 11, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.